Pharmaceutical

IDWeek 2024: strategic approaches and challenges in mpox vaccination

At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly known as monkeypox) were discussed.

Nov 13, 2024 - 06:00
IDWeek 2024: strategic approaches and challenges in mpox vaccination
At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly known as monkeypox) were discussed.
Read the original article

Tags:

Previous Article

Uppsala and KTH Royal develop antibody for potential cancer treatment

Next Article

Zai Lab and argenx announce NMPA approval for sBLA for VYVGART Hytrulo

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Hoth and Aronnax partner for HT-KIT cancer therapy development

Hoth and Aronnax partner for HT-KIT cancer therapy deve...

Aug 17, 2024

America’s ERs struggle with timely care for stroke patients

America’s ERs struggle with timely care for stroke pati...

Aug 15, 2023

Key questions (and answers) about the historic approval of a CRISPR-based medicine

Key questions (and answers) about the historic approval...

Nov 17, 2023